Indication
Chronic kidney disease associated with type 1 diabetes mellitus
**Chronic kidney disease associated with type 1 diabetes mellitus** (often referred to as diabetic kidney disease or diabetic nephropathy) is a progressive microvascular complication affecting individuals with autoimmune, insulin-dependent diabetes. Read more about Chronic kidney disease associated with type 1 diabetes mellitus
1 drugs 1 manufacturers
Drugs that treat it
Common Chronic kidney disease associated with type 1 diabetes mellitus therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon**Chronic kidney disease associated with type 1 diabetes mellitus** (often referred to as diabetic kidney disease or diabetic nephropathy) is a progressive microvascular complication affecting individuals with autoimmune, insulin-dependent diabetes.
It is characterized by renal structural and functional impairment, clinically defined by persistent albuminuria (urine albumin-to-creatinine ratio =30 mg/g) and/or a sustained decline in estimated glomerular filtration rate (<60 mL/min/1.73 m²) lasting at least three months.
Pathophysiologically, chronic hyperglycemia and intraglomerular hypertension induce glomerular hyperfiltration, mesangial matrix expansion, glomerular basement membrane thickening, and podocyte loss, ultimately progressing to nodular glomerulosclerosis, tubulointerstitial fibrosis, and potential end-stage renal disease.
- nih.gov
**Chronic kidney disease associated with type 1 diabetes mellitus** (often referred to as diabetic kidney disease or diabetic nephropathy) is a progressive microvascular complication affecting individuals with autoimmune, insulin-dependent diabetes
- healthline.com
**Chronic kidney disease associated with type 1 diabetes mellitus** (often referred to as diabetic kidney disease or diabetic nephropathy) is a progressive microvascular complication affecting individuals with autoimmune, insulin-dependent diabetes
- diabetes.org
It is characterized by renal structural and functional impairment, clinically defined by persistent albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) and/or a sustained decline in estimated glomerular filtration rate (<60 mL/min/1.73 m²) lasting at least three months
- nih.gov
It is characterized by renal structural and functional impairment, clinically defined by persistent albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) and/or a sustained decline in estimated glomerular filtration rate (<60 mL/min/1.73 m²) lasting at least three months
- nih.gov
It is characterized by renal structural and functional impairment, clinically defined by persistent albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) and/or a sustained decline in estimated glomerular filtration rate (<60 mL/min/1.73 m²) lasting at least three months Pathophysiologically, chronic hyperglycemia and intraglomerular hypertension induce glomerular hyperfiltration, mesangial matrix expansion, glomerular basement membrane thickening, and podocyte loss, ultimately progressing to...
- cdc.gov
Pathophysiologically, chronic hyperglycemia and intraglomerular hypertension induce glomerular hyperfiltration, mesangial matrix expansion, glomerular basement membrane thickening, and podocyte loss, ultimately progressing to nodular glomerulosclerosis, tubulointerstitial fibrosis, and potential end-stage renal disease
Personalize your experience
Follow Chronic kidney disease associated with type 1 diabetes mellitus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.